Science China Materials

, Volume 60, Issue 6, pp 529–542 | Cite as

Hydrophobe-substituted bPEI derivatives: boosting transfection on primary vascular cells

  • Daniele Pezzoli
  • Eleni K. Tsekoura
  • K.C. Remant Bahadur
  • Gabriele Candiani
  • Diego Mantovani
  • Hasan Uludağ
Articles

Abstract

Gene therapy targeted to vascular cells represents a promising approach for prevention and treatment of pathological conditions such as intimal hyperplasia, in-stent and post-angioplasty restenosis. In this context, polymeric non-viral gene delivery systems are a safe alternative to viral vectors but a further improvement in efficiency and cytocompatibility is needed to improve their clinical success. Herein, a library of 24 branched polyethylenimine (bPEI) derivatives modified with hydrophobic moieties was synthesised, characterised and tested in vitro on primary vascular cells, aiming to identify delivery agents with superior transfection efficiency and low cytotoxicity. Low molecular weight PEIs (0.6, 1.2 and 2 kDa) were grafted with long (C18) and short (C3) aliphatic chains, featuring different unsaturation degrees and degrees of substitution. 0.6 kDa bPEI-based derivatives were generally ineffective in transfection on vascular smooth muscle cells (VSMCs), while among the other derivatives some promising vectors were identified. Forcing polyplexes on the cell surface by means of centrifugation invariably boosted transfection levels but increased cytotoxicity as well. Of note, a propionyl-substituted derivative (PEI2-PrA1, C3:0) was the most effective on both VSMCs and endothelial cells (ECs), with higher and more sustained gene expression in combination with markedly lower cytotoxicity with respect to the gold standard 25 kDa bPEI. In addition, a linoleoyl-substituted derivative (PEI1.2-LA6, C18:2) owing to its high efficiency in VSMCs and relative inefficacy in ECs, combined with tolerable cytotoxicity was proposed as a vector for specific VSMCs targeting.

Keywords

non-viral gene delivery polyethylenimine hydrophobic substitution smooth muscle cells endothelial cells transfection 

疏水基取代的分枝状聚乙酰亚胺衍生物:促进原发性血管细胞中的转染

摘要

针对血管细胞的基因治疗代表了一种有望用于预防和治疗内膜增生、血管支架狭窄和血管成形术后狭窄等病理状态的方法. 聚合 物非病毒载体的基因传递系统可以安全替代病毒载体, 但是为了提高临床效果, 它们的治疗效率及细胞相容性还需要进一步改善. 本文合 成了一系列24种被疏水基团修饰的分枝状聚乙酰亚胺衍生物(bPEI), 并进行了表征及在体外原发性血管细胞内的测试, 旨在筛选出具有优 异的转染效率和低细胞毒性的传递剂. 低分子量的聚乙酰亚胺(0.6, 1.2 and 2 kDa)以不同取代程度接枝上了不同饱和度的长(C18)和短(C3) 的不饱和脂肪链. 丙酰取代衍生物(PEI2-PrA1, C3:0)在血管平滑肌细胞和内皮细胞转染中是最有效的, 与著名的黄金标准25 kDa bPEI相比, 具有更优异、更持久的基因表达, 且毒性更低. 此外, 亚油酰基取代衍生物(PEI1.2-LA6, C18:2) 由于在血管平滑肌细胞转染过程中效率高, 而在内皮细胞中相对无效, 且其具有可容忍的细胞毒性, 可作为特定靶向于血管平滑肌细胞的载体.

Supplementary material

40843_2017_9030_MOESM1_ESM.pdf (1 mb)
Hydrophobe-substituted bPEI derivatives: boosting transfection on primary vascular cells

References

  1. 1.
    Mozaffarian D, Benjamin EJ, Go AS, et al. Executive summary: heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation, 2015, 131: 434–441CrossRefGoogle Scholar
  2. 2.
    Shan L, Saxena A, McMahon R, et al. Coronary artery bypass graft surgery in the elderly: a review of postoperative quality of life. Circulation, 2013, 128: 2333–2343CrossRefGoogle Scholar
  3. 3.
    Marx SO, Totary-Jain H, Marks AR. Vascular smooth muscle cell proliferation in restenosis. Circ-Cardiovasc Interv, 2011, 4: 104–111CrossRefGoogle Scholar
  4. 4.
    Bauters C, Isner J. The biology of restenosis. Prog Cardiovasc Dis, 1997, 40: 107–116CrossRefGoogle Scholar
  5. 5.
    Arnold JD, Mountain DJH, Freeman MB, et al. Smooth muscle cell polymeric transfection is an efficient alternative to traditional methods of experimental gene therapy. J Surg Res, 2012, 177: 178–184CrossRefGoogle Scholar
  6. 6.
    Fang YL, Chen XG, Godbey WT. Gene delivery in tissue engineering and regenerative medicine. J Biomed Mater Res, 2015, 103: 1679–1699CrossRefGoogle Scholar
  7. 7.
    Dean DA. Nonviral gene transfer to skeletal, smooth, and cardiac muscle in living animals. AJP-Cell Physiol, 2005, 289: C233–C245CrossRefGoogle Scholar
  8. 8.
    Pezzoli D, Chiesa R, De Nardo L, et al. We still have a long way to go to effectively deliver genes! J Appl Biomater Funct Mater, 2012, 2: 82–91Google Scholar
  9. 9.
    Pezzoli D, Candiani G. Non-viral gene delivery strategies for gene therapy: a “ménage à trois” among nucleic acids, materials, and the biological environment. J Nanopart Res, 2013, 15: 1523CrossRefGoogle Scholar
  10. 10.
    Akinc A, Thomas M, Klibanov AM, et al. Exploring polyethylenimine- mediated DNA transfection and the proton sponge hypothesis. J Gene Med, 2005, 7: 657–663CrossRefGoogle Scholar
  11. 11.
    Mintzer MA, Simanek EE. Nonviral vectors for gene delivery. Chem Rev, 2009, 109: 259–302CrossRefGoogle Scholar
  12. 12.
    Pezzoli D, Olimpieri F, Malloggi C, et al. Chitosan-graft-branched polyethylenimine copolymers: influence of degree of grafting on transfection behavior. PLoS ONE, 2012, 7: e34711CrossRefGoogle Scholar
  13. 13.
    Alshamsan A, Haddadi A, Incani V, et al. Formulation and delivery of si RNA by oleic acid and stearic acid modified polyethylenimine. Mol Pharm, 2009, 6: 121–133CrossRefGoogle Scholar
  14. 14.
    Han S, Mahato RI, Kim SW. Water-soluble lipopolymer for gene delivery. Bioconjugate Chem, 2001, 12: 337–345CrossRefGoogle Scholar
  15. 15.
    Thomas M, Klibanov AM. Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells. Proc Natl Acad Sci USA, 2002, 99: 14640–14645CrossRefGoogle Scholar
  16. 16.
    Zheng M, Zhong Y, Meng F, et al. Lipoic acid modified low molecular weight polyethyleniminemediates nontoxic and highly potent in vitro gene transfection. Mol Pharm, 2011, 8: 2434–2443CrossRefGoogle Scholar
  17. 17.
    Neamnark A, Suwantong O, Bahadur RKC, et al. Aliphatic lipid substitution on 2 k Da polyethylenimine improves plasmid delivery and transgene expression. Mol Pharm, 2009, 6: 1798–1815CrossRefGoogle Scholar
  18. 18.
    Bahadur KCR, Landry B, Aliabadi HM, et al. Lipid substitution on low molecular weight (0. 6–2. 0k Da) polyethylenimine leads to a higher zeta potential of plasmid DNA and enhances transgene expression. Acta Biomater, 2011, 7: 2209–2217CrossRefGoogle Scholar
  19. 19.
    Thapa B, Plianwong S, Remant Bahadur KC, et al. Small hydrophobe substitution on polyethylenimine for plasmid DNA delivery: optimal substitution is critical for effective delivery. Acta Biomater, 2016, 33: 213–224CrossRefGoogle Scholar
  20. 20.
    D'Andrea C, Pezzoli D, Malloggi C, et al. The study of polyplex formation and stability by time-resolved fluorescence spectroscopy of SYBR Green I-stained DNA. Photochem Photobiol Sci, 2014, 13: 1680–1689CrossRefGoogle Scholar
  21. 21.
    Pezzoli D, Kajaste-Rudnitski A, Chiesa R, et al. Lipid-based nanoparticles as nonviral gene delivery vectors. In: Bergese P, Hamad-Schifferli K (eds.). Nanomaterial Interfaces in Biology: Methods and Protocols, Methods in Molecular Biology. New York: Humana Press, 2013, 1025: 269–279CrossRefGoogle Scholar
  22. 22.
    Chang KH, Park JM, Lee MY. Feasibility of simultaneous measurement of cytosolic calcium and hydrogen peroxide in vascular smooth muscle cells. BMB Rep, 2013, 46: 600–605CrossRefGoogle Scholar
  23. 23.
    Fan Z, Chen D, Deng CX. Improving ultrasound gene transfection efficiency by controlling ultrasound excitation of microbubbles. J Control Release, 2013, 170: 401–413CrossRefGoogle Scholar
  24. 24.
    Gresch O, Altrogge L. Transfection of difficult-to-transfect primary mammalian cells. In: Hartley JL (ed.). Protein Expression in Mammalian Cells: Methods and Protocols, Methods in Molecular Biology. New York: Humana Press, 2012, 801: 65–74CrossRefGoogle Scholar
  25. 25.
    Hsu CYM, Hendzel M, Uludag H. Improved transfection efficiency of an aliphatic lipid substituted 2 k Da polyethylenimine is attributed to enhanced nuclear association and uptake in rat bone marrow stromal cell. J Gene Med, 2011, 13: 46–59CrossRefGoogle Scholar
  26. 26.
    Pezzoli D, Giupponi E, Mantovani D, et al. Size matters for in vitro gene delivery: investigating the relationships among complexation protocol, transfection medium, size and sedimentation. Sci Rep, 2017, 7: 44134CrossRefGoogle Scholar
  27. 27.
    Suzuki Y, Yeung AC, Ikeno F. The representative porcinemodel for human cardiovascular disease. J Biomed Biotech, 2011, 2011: 1–10Google Scholar
  28. 28.
    Malloggi C, Pezzoli D, Magagnin L, et al. Comparative evaluation and optimization of off-the-shelf cationic polymers for gene delivery purposes. Polym Chem, 2015, 6: 6325–6339CrossRefGoogle Scholar
  29. 29.
    Dube B, Rose L, Sawant K, et al. Cholic acid modified 2 k Da polyethylenimine as efficient transfection agent. Biotechnol Prog, 2013, 29: 1337–1341CrossRefGoogle Scholar
  30. 30.
    Zhang QF, Luan CR, Yin DX, et al. Amino acid-modified polyethylenimines with enhanced gene delivery efficiency and biocompatibility. Polymers, 2015, 7: 2316–2331CrossRefGoogle Scholar
  31. 31.
    Pezzoli D, Tarsini P, Melone L, et al. RGD-derivatized PEI-PEG copolymers: influence of the degree of substitution on the targeting behavior. J Drug Deliver Sci Tech, 2017, 37: 115–122CrossRefGoogle Scholar
  32. 32.
    Breunig M, Lungwitz U, Liebl R, et al. Breaking up the correlation between efficacy and toxicity for nonviral gene delivery. Proc Natl Acad Sci USA, 2007, 104: 14454–14459CrossRefGoogle Scholar
  33. 33.
    Aliabadi HM, Landry B, Bahadur RK, et al. Impact of lipid substitution on assembly and delivery of si RNA by cationic polymers. Macromol Biosci, 2011, 11: 662–672CrossRefGoogle Scholar
  34. 34.
    Hsu CYM, Uludag H. A simple and rapid nonviral approach to efficiently transfect primary tissue-derived cells using polyethylenimine. Nat Protoc, 2012, 7: 935–945CrossRefGoogle Scholar
  35. 35.
    Fishbein I, Chorny M, Adamo RF, et al. Endovascular gene delivery from a stent platform: gene- eluting stents. Angiol, 2013, 1: 1000109Google Scholar
  36. 36.
    Saurer EM, Yamanouchi D, Liu B, et al. Delivery of plasmid DNA to vascular tissue in vivo using catheter balloons coated with polyelectrolyte multilayers. Biomaterials, 2011, 32: 610–618CrossRefGoogle Scholar
  37. 37.
    Riessen R, Rahimizadeh H, Blessing E, et al. Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon. Hum Gene Ther, 1993, 4: 749–758CrossRefGoogle Scholar
  38. 38.
    Sharif F, Hynes SO, Cooney R, et al. Gene-eluting stents: adenovirus- mediated delivery of e NOS to the blood vessel wall accelerates re-endothelialization and inhibits restenosis. Mol Therapy, 2008, 16: 1674–1680CrossRefGoogle Scholar
  39. 39.
    Patel SD, Waltham M, Wadoodi A, et al. The role of endothelial cells and their progenitors in intimal hyperplasia. Therapeutic Adv Cardiovascular Disease, 2010, 4: 129–141CrossRefGoogle Scholar

Copyright information

© Science China Press and Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  • Daniele Pezzoli
    • 1
  • Eleni K. Tsekoura
    • 2
  • K.C. Remant Bahadur
    • 2
  • Gabriele Candiani
    • 3
  • Diego Mantovani
    • 1
  • Hasan Uludağ
    • 2
  1. 1.Laboratory for Biomaterials and Bioengineering, CRC- I, Department of Mining, Metallurgical and Materials Engineering and CHU de Québec Research CentreLaval UniversityQuebec CityCanada
  2. 2.Department of Chemical & Material Engineering, Faculty of EngineeringUniversity of AlbertaEdmontonCanada
  3. 3.Department of Chemistry, Materials and Chemical Engineering “Giulio Natta”Politecnico di MilanoMilanItaly

Personalised recommendations